Karim Mikhail is to resign as president and chief executive of Amarin Corp, the Ireland-headquartered fish oil-based heart drug specialist, according to a US Se 3 April 2023
Karen Harrison has been named chief operating officer of the Therapeutics Division at Avacta, a UK-based life sciences company developing targeted oncology drug 29 March 2023
US biopharma Inozyme Pharma has announced that founding chief executive officer Axel Bolte will retire from his current role, to be replaced by Douglas Treco. 24 March 2023
Beam Therapeutics, a US biotech developing precision genetic medicines through base editing, has named Gopi Shanker its chief scientific officer (CSO). 22 March 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.